About
Technology
Issues
FAQ
Links
Official Page
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.